Whey Protein Concentrate for Food Intolerance

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
The University of the Incarnate Word, San Antonio, TX
Food Intolerance+1 More
Whey Protein Concentrate - DietarySupplement
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether whey protein supplementation affects athletic performance and recovery in people with and without whey protein sensitivity. Whey Protein Concentrate is used to treat food intolerance and has been approved by the FDA for a different condition. No patients in this trial will receive a placebo.

Eligible Conditions

  • Food Intolerance

Treatment Effectiveness

Study Objectives

3 Primary · 3 Secondary · Reporting Duration: Baseline

Baseline
Number of Athletes with Whey Sensitivity
Week 10
Change from Baseline InBody Body Composition Test at 4 weeks
Change from Baseline Performance Questionnaire at 4 weeks
Change from Baseline Vertical Jump Test at 4 weeks
Number of Participants with Declining Measures
Number of Participants with Increasing Measures

Trial Safety

Trial Design

3 Treatment Groups

Control Group: Subjects with no protien intake
1 of 3
Plant-based Protein, Then Whey Protein
1 of 3
Whey Protein, Then Plant-based Protein
1 of 3
Active Control
Experimental Treatment

60 Total Participants · 3 Treatment Groups

Primary Treatment: Whey Protein Concentrate · No Placebo Group · N/A

Plant-based Protein, Then Whey ProteinExperimental Group · 2 Interventions: Whey Protein Concentrate, Pea Protein Isolate, Rice Protein Concentrate, Hemp Protein · Intervention Types: DietarySupplement, DietarySupplement
Whey Protein, Then Plant-based ProteinExperimental Group · 2 Interventions: Whey Protein Concentrate, Pea Protein Isolate, Rice Protein Concentrate, Hemp Protein · Intervention Types: DietarySupplement, DietarySupplement
Control Group: Subjects with no protien intakeNoIntervention Group · 1 Intervention: Control Group: Subjects with no protien intake · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline
Closest Location: The University of the Incarnate Word · San Antonio, TX
Photo of San Antonio 1Photo of San Antonio 2Photo of San Antonio 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Food Intolerance
0 CompletedClinical Trials

Who is running the clinical trial?

University of the Incarnate WordLead Sponsor
14 Previous Clinical Trials
3,439 Total Patients Enrolled
Brittanie L Lockard, PhDPrincipal InvestigatorUniversity of the Incarnate Word

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are a member of the NCAA Division I at the University of the Incarnate Word.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References